Skip to main content
Consun Pharmaceutical Group Limited logo

Consun Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 1681 HKEX Manufacturing
Open in API
Filings indexed 849 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1681

About Consun Pharmaceutical Group Limited

http://www.chinaconsun.com

Consun Pharmaceutical Group Limited is a modern pharmaceutical enterprise engaged in the integrated research, development, manufacturing, and marketing of pharmaceutical products. The company's core business is segmented into Modern Chinese Medicines (MCM) and Medical Contrast Medium products. The MCM portfolio targets major therapeutic areas, including chronic renal diseases (featuring products like Uremic Clearance Granules), liver and gallbladder conditions, and orthopedic trauma. In the medical imaging field, Consun supplies contrast agents such as Gadopentetate Dimeglumine Injection for magnetic resonance imaging (MRI) and Iopamidol Injection for angiography and neuro-radiology. The enterprise focuses on combining the modernization of Chinese medicine with advanced diagnostic solutions.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings
2026-05-04 English
2025 Environmental, Social and Governance Report
Regulatory Filings
2026-04-28 English
ANNUAL REPORT 2025
Regulatory Filings
2026-04-28 English
Notification Letter to Shareholders - Annual General Meeting
AGM Information Classification · 1% confidence The document is an official notice addressed to shareholders of Consun Pharmaceutical Group Limited regarding the Annual General Meeting (AGM), providing the date, time, venue (physical and online), log-in details, and attendance instructions. It does not contain financial results or proxy voting results, nor is it a standalone financial report. This clearly falls under AGM Information.
2026-04-28 Chinese
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is the official Form of Proxy for the Annual General Meeting, which is a solicitation document sent to shareholders to provide information about the meeting and to request their votes. This matches the definition for Proxy Solicitation & Information Statement (Code: PSI).
2026-04-28 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice convening the Annual General Meeting (AGM) of Consun Pharmaceutical Group Limited. It sets out the agenda items (approval of financial statements, re-election of directors, dividend declaration, auditor re-appointment, share issue and repurchase mandates), details on proxies, registration and voting procedures, and explanatory notes. This is clearly a shareholder solicitation document used to request votes for resolutions at an AGM, matching the description of a Proxy Solicitation & Information Statement.
2026-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.